Specialty drug costs have gotten a lot of attention, but more concerning is some ways is the recent surge in prices of many generic drugs.
A report from Deloitte’s Center for Health Solutions explores current consumer use of health information technologies.
The Kaiser Family Foundation looks at the latest data in regard to Medicare geographic spending variation.
A PWC Health Research Institute brief examines various forms of provider payment reforms.
The Commonwealth Fund reviews relative performance of the health systems of 13 developed countries, finding that the US spends the most but doesn’t have the best outcomes. The report has the usual flaws.
A formal evaluation of the effects of all the federal health information technology initiatives, including meaningful use of EHRs, finds little evidence of the promised benefits.
Two recent reports discuss the state of financing for “digital” health companies.
Large employers surveyed by the National Business Group on Health expect a modest increase in health benefit costs in 2015 but continued cost-shifting to employees.
Another of my favorite annual reports is out, this one from AHRQ on the concentration of health spending in the US population.
According to a Government Accounting Office Report, so far not much to show from CMS’ hospital value-based purchasing program.